Sarepta Therapeutics (SRPT) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/02/22
Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/02/22
Sarepta Therapeutics Announces Second Quarter 2022 Financial Results and Recent Corporate DevelopmentsGlobeNewsWire • 08/02/22
Strength Seen in Sarepta Therapeutics (SRPT): Can Its 8.2% Jump Turn into More Strength?Zacks Investment Research • 08/01/22
Sarepta Therapeutics Announces Intent to Submit an Accelerated Approval Biologics License Application for its Gene Therapy SRP-9001 to Treat Duchenne Muscular DystrophyGlobeNewsWire • 07/29/22
Sarepta Therapeutics to Announce Second Quarter 2022 Financial Results and Recent Corporate Developments on August 2, 2022GlobeNewsWire • 07/26/22
Here's Why Sarepta Therapeutics (SRPT) is a Great Momentum Stock to BuyZacks Investment Research • 07/12/22
Sarepta Therapeutics' Investigational Gene Therapy SRP-9001 for Duchenne Muscular Dystrophy Demonstrates Significant Functional Improvements Across Multiple StudiesGlobeNewsWire • 07/06/22
Sarepta Therapeutics to Share New Clinical Data and Integrated Analysis for SRP-9001, its Investigational Gene Therapy for the Treatment of Duchenne Muscular Dystrophy on July 6, 2022 at 8:30am ETGlobeNewsWire • 07/05/22
Sarepta Therapeutics Provides Update on SRP-5051 for the Treatment of Duchenne Muscular DystrophyGlobeNewsWire • 06/23/22
Why Is Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report?Zacks Investment Research • 06/03/22
Sarepta Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare ConferenceGlobeNewsWire • 06/02/22
Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/05/22
Sarepta Therapeutics to Present at the BofA Securities 2022 Healthcare ConferenceGlobeNewsWire • 05/04/22
Sarepta Therapeutics (SRPT) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseZacks Investment Research • 04/27/22
Sarepta Therapeutics to Announce First Quarter 2022 Financial Results and Recent Corporate Developments on May 4, 2022GlobeNewsWire • 04/27/22